Post-effective amendment to a registration statement that is not immediately effective upon filing

Long-Term Debt - Additional Information (Details)

v3.22.2.2
Long-Term Debt - Additional Information (Details) - P3 Health Partners Inc.
6 Months Ended 11 Months Ended 12 Months Ended
Nov. 19, 2020
USD ($)
shareholder
payment
Jun. 07, 2020
USD ($)
$ / shares
shares
Jun. 30, 2022
USD ($)
payment
$ / shares
shares
Dec. 02, 2021
USD ($)
Dec. 31, 2025
USD ($)
Dec. 31, 2024
USD ($)
Dec. 31, 2023
USD ($)
Dec. 31, 2022
USD ($)
Dec. 31, 2021
USD ($)
Dec. 31, 2020
USD ($)
Dec. 03, 2021
USD ($)
Dec. 31, 2019
USD ($)
shareholder
Debt Instrument [Line Items]                        
Debt outstanding     $ 80,000,000 $ 80,053,526         $ 80,046,101 $ 55,136,089 $ 80,053,526 $ 16,516,598
Net proceeds from debt       25,000,000           40,180,000    
Percentage of pledged stock, Its subsidiaries and bank accounts     100.00%                  
Class C Preferred Units                        
Debt Instrument [Line Items]                        
Number of share-purchase agreement | shareholder                       1
Share price | $ / shares   $ 0.90                    
Shares repurchased | shares   200,000                    
Members deficit decrease   $ 180,000                    
LTD-C                        
Debt Instrument [Line Items]                        
Debt outstanding     $ 15,000,000 15,000,000         15,000,000 15,000,000 15,000,000 $ 15,000,000
Net proceeds from debt $ 15,000,000.0                      
Interest rate 11.00%                      
Number of share-purchase agreement | shareholder 1                      
Amount exit fee due at maturity $ 600,000                      
Debt instrument accrued interest     7,710,876           6,511,477      
Notes payable related parties 15,000,000.0                      
LTD-D                        
Debt Instrument [Line Items]                        
Debt face amount $ 100,000,000                      
Debt outstanding     65,000,000 65,000,000         65,000,000 40,000,000 65,000,000  
Net proceeds from debt     61,058,281 25,000,000         61,058,281 40,000,000    
Debt issuance cost     3,941,719           3,941,719      
Accrued interest     $ 3,619,054           2,259,588      
Period when revenue should greater than or equal to $125.0 million 3 months                      
Minimum revenue $ 125,000,000.0       $ 650,000,000.0 $ 585,000,000.0 $ 525,000,000.0 $ 460,000,000.0 395,000,000.0      
Minimum liquidity $ 5,000,000.0                      
Paid in cash interest, percentage 12.00%   12.00%                  
Partially paid in kind interest, percentage 8.00%   8.00%                  
Gross proceeds from debt     $ 65,000,000           65,000,000      
Paid in kind interest, percentage 4.00%   4.00%                  
Interest payment term 3 years   3 years                  
Number of payments | payment 12   12                  
Warrant term     10 years                  
Warrant issued for securities | shares     858,351                  
Share price | $ / shares     $ 4.68                  
Percentage of pledged stock, Its subsidiaries and bank accounts 100.00%                      
LTD-E                        
Debt Instrument [Line Items]                        
Debt outstanding       $ 53,526         $ 46,101 136,089 $ 53,526  
Net proceeds from debt                   $ 180,000    
Interest rate   3.25%                    
Monthly payment   $ 7,757                    
LTD-E | Class C Preferred Units                        
Debt Instrument [Line Items]                        
Members deficit decrease   180,000                    
Monthly payment   $ 7,757